Clinical Trials Browser

Phase 2 × OTHER × Lamivudine × Clear all

NCT04696575 2025-12-15

Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer

Phase 2 Recruiting

Extensive Stage Lung Small Cell Carcinoma

NCT03144804 2024-06-06

A Phase 2 Study of Lamivudine in Patients With p53 Mutant Metastatic Colorectal Cancer

Phase 2 Completed

36 enrolled 11 charts

Gastrointestinal

Colorectal Neoplasms

NCT01914744 2013-08-02

Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHL

Phase 2 Unknown

Lymphoma, Non-Hodgkin